Pharmafile Logo
Pharmafocus logo
Advanced Search

Alphamab Oncology and 3DMedicines enter licensing agreement with Glenmark Speciality

January 25, 2024
Medical Communications 3DMedicines, Alphamab Oncology, Glenmark Speciality, Oncology, envafolimab

Alphamb Oncology and 3DMedicines have announced that they have entered into a license agreement with Glenmark Speciality, a subsidiary of …

News

Futura Medical appoints Roy Davis as non-executive director

January 25, 2024
Business Services Futura Medical, Roy Davis, appointment, non-executive director

Futura Medical has announced the appointment of Roy Davis as non-executive director effective immediately. Roy has extensive commercial experience in …

Appointment

Cellular Origins appoints Peter Crossley as chief operating officer

January 25, 2024
Business Services Cellular Origins, Peter Crossley, appointment, chief operating officer

Cellular Origins, a TTP Company, has announced that it has appointed Peter Crossley as chief operating officer (COO). Peter brings …

Appointment

BenevolentAI appoints Dr Joerg Moeller as CEO

January 25, 2024
Business Services BenevolentAI, CEO, Dr Joerg Moeller, appointment

BenevolentAI has announced that it has appointed Dr Joerg Moeller MD PhD as chief executive officer and executive board member …

Appointment

Onward Therapeutics announces enrolment of phase 1 trial of bispecific antibody

January 24, 2024
Research and Development Oncology, Onward Therapeutics, bispecific antibody, clinical trial

Onward Therapeutics has announced that it has begun enrolment for its phase 1 clinical trial of OT-A201, a novel bispecific …

News

InnoCare announces first patient dosed in zurletrectinib clinical trial in China

January 24, 2024
Research and Development InnoCare, Oncology, clinical trial, zurletrectinib

InnoCare Pharma has announced that the first paediatric patient has been dosed in a clinical trial of the company’s second …

News

CN Bio and Altis Biosystems partner for development of in vitro model for ADME studies

January 23, 2024
Research and Development ADME studies, Altis Biosystems, CN Bio, Pharmacy

CN Bio and Altis Biosystems have announced that they will enter a strategic partnership, through which Altis’ human RepliGut Planar-Jejunum …

News

Sanofi to acquire Inhibrx for approximately $1.7bn

January 23, 2024
Business Services Inhibrx, Rare Diseases, Sanofi, acquisition

Sanofi and Inhibrx, Inc have announced that they have entered into a definitive agreement for Sanofi to acquire Inhibrx following …

News

UKHSA warns of measles outbreak

January 22, 2024
Medical Communications Infections and infestations, MMR, UKHSA, measles, vaccination

The UK Health Security Agency (UKHSA) has warned that further outbreaks of measles could spread to other towns and cities …

News

FDA approves Balversa for bladder cancer treatment

January 22, 2024
Medical Communications Balversa, FDA, Johnson & Johnson, Oncology, bladder cancer

Johnson & Johnson (J&J) have announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug …

News
anirudh-djo3injpaoe-unsplash_3

AstraZeneca’s Voydeya approved in Japan for PNH treatment

January 19, 2024
Medical Communications AstraZeneca, Haematology, PNH, Voydeya

AstraZeneca has announced that Voydeya (danicopan) has been approved in Japan for the treatment of paroxysmal nocturnal haemoglobinuria (PNH), in …

News

Verastem Oncology gains Fast Track Designation for combination NSCLC treatment

January 19, 2024
Medical Communications Cancer, FDA, NSCLC, Oncology, Verastem Oncology

Verastem Oncology has announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation to the company’s …

News

FDA clears DermaSensor’s AI detection device for skin cancer

January 18, 2024
Medical Communications FDA, Oncology, skin cancer

DermaSensor has announced that the US Food and Drug Administration (FDA) has granted clearance for its real-time, non-invasive skin cancer …

News

Arcus Biosciences shares results from phase 1b trial for pancreatic cancer treatment

January 18, 2024
Medical Communications Arcus Biosciences, Oncology, Pancreatic cancer, clinical trial

Arcus Biosciences has announced new data from the ARC-8 phase 1b clinical study which is being co-developed alongside Gilead Sciences. …

News

FDA clears Aruna Bio’s IND for AB126 to enter clinical trials

January 17, 2024
Research and Development Aruna Bio, FDA, IND, Neurology, clinical trials

Aruna Bio has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application …

News

Qlucore and Sahlgrenska Hospital sign agreement for ALL diagnosis software

January 17, 2024
Business Services Oncology, Qlucore, Sahlgrenska Hospital, acute lymphoblastic leukaemia, leukaemia

Qlucore has announced that it has entered into an agreement with Sahlgrenska Hospital, in Gothenberg, Sweden. This agreement means the …

News

Upperton Pharma Solutions announces £5m investment into sterile drug manufacturing

January 16, 2024
Manufacturing and Production Pharmacy, Upperton Pharma Solutions, investment, sterile drug manufacturing

UK-based contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions has announced a £5m investment to expand into a small-scale …

News

DelSiTech announces closing of €10m financing round for silica-based drug delivery platform

January 16, 2024
Manufacturing and Production DelSiTech, Pharmacy, drug delivery, investment, manufacturing

DelSiTech has announced the successful completion of a €10m financing round, marking the largest single financing round in the company’s …

News

FDA approves Merck’s Keytruda with chemoradiotherapy as cervical cancer treatment

January 15, 2024
Medical Communications FDA, Oncology, cervical cancer, keytruda

Merck, known as MSD outside of the US and Canada, has announced that the US Food and Drug Administration (FDA) …

News

Boan Biotech completes enrolment for phase 3 study of Denosumab

January 15, 2024
Research and Development Boan Biotech, Pharmacy, biosimilar, clinical trial, denosumab

Boan Biotech has announced that it has completed subject enrolment for its international multicentre comparative phase 3 clinical trial of …

News

Latest content

AstraZeneca to build $1.5bn ADC facility in Singapore

May 20, 2024

ERS Genomics and IRBM sign license agreement for CRISPR/Cas9

May 20, 2024

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024